作者单位:
Novartis Institutes of BioMedical Research, Preclinical Safety, WKL-136.1.16, 4002 Basel
[1]
Janssen Research and Development, Beerse, Belgium
[2]
Hoffmann-La Roche, Non-Clinical Drug Safety, 4070 Basel, Switzerland
[3]
GSK, GlaxoSmithKline, Platform Technology and Sciences, King of Prussia, PA 19406, United States
[4]
Sanofi R and D, Montpellier, France
[5]
GSK, GlaxoSmithKline, Projects Clinical Platform and Sciences, King of Prussia, PA 19406, United
[6]
Global Research and Development, Groton, CT 06340, United States
[7]
发布时间
2014-05-21